Metered Cryospray Therapy Linked to Airway Remodeling in Chronic Bronchitis
Data shows that metered cryospray therapy with the investigational RejuvenAir System leads to airway remodeling and improved symptoms in chronic bronchitis patients.
Data shows that metered cryospray therapy with the investigational RejuvenAir System leads to airway remodeling and improved symptoms in chronic bronchitis patients.
Patients receiving the drug also had slightly more side effects and needed more care from hospitals and family members.
The five-part plan aims to reduce wildfire-related health risks, particularly for those with COPD and asthma, using a population health-based approach.
The inhaled therapy for the maintenance treatment of COPD combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule.
Read MoreThe American Lung Association’s new Wellness Hub offers free resources designed to enhance the physical and mental well-being of lung disease patients.
Read MoreA new project aimed at increasing the use of digital endpoints in clinical trials is being spearheaded by the COPD Foundation in collaboration with the Digital Medicine Society.
Read MoreThe study is designed to determine the safety and efficacy of lung denervation with the AerWave device in patients with COPD and asthma.
Read MoreBoehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patients for the company’s inhalers is now available, according to the company.
Read MoreIn hospital settings, the terms “NIV” and “BiPAP” are often used synonymously. However, when patients are being discharged to home care, the exact terminology used by physicians is essential in order to prescribe the precise therapy.
Read MoreIdentifying and treating people with previously undiagnosed asthma or COPD led to improved respiratory symptoms, quality of life, and reduced healthcare visits in the year after diagnosis.
Read MoreThe CT-derived functional imaging software provides lung diagnostics without the need for contrast dye, which could benefit up to 30% of patients allergic to dye or with dye restrictions.
Read MoreEliminating racially adjusted spirometry results could lead to a significant increase in Black patient participation in COPD clinical trials, according to findings presented at ATS 2024.
Read MoreNew data presented at ATS 2024 show the potential of Tezspire to play a role in the future treatment of COPD.
Read MoreFinancial assistance from The Assistance Fund is now available for eligible people living with chronic obstructive pulmonary disease.
Read MoreCOPD cases in women are projected to increase at a rate five times higher than in men through 2050, while reproductive factors emerge as potential risk markers.
Read More